Tung-Fen Chen

Title: Innovations by Tung-Fen Chen

Introduction

Tung-Fen Chen is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of drug delivery systems. With a total of 2 patents, his work focuses on enhancing the efficacy of transdermal drug delivery methods.

Latest Patents

Chen's latest patents include innovative technologies such as polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems. These high-capacity drug reservoirs are formulated from polyurethanes that are crosslinked with diisocyanate agents or cured with radiation in the presence of a photoinitiator. The reservoirs can achieve drug loading as high as 65 to 70 wt. % or more by absorbing drug formulations after hydrogel synthesis. Additionally, he has developed methods for making and using transdermal systems that incorporate these reservoirs. Another significant patent involves the transdermal administration of ropinirole and its analogs, which are dopamine D2 agonists. This method is particularly beneficial for treating individuals afflicted with Parkinson's disease, allowing for effective symptom alleviation through skin or mucosal tissue administration.

Career Highlights

Tung-Fen Chen is currently employed at Cygnus, Inc., where he continues to innovate in the field of pharmaceutical formulations and drug delivery systems. His work has been instrumental in advancing transdermal drug delivery technologies.

Collaborations

Chen collaborates with talented individuals such as Chia-Ming Chiang and Janan Jona, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tung-Fen Chen's contributions to transdermal drug delivery systems exemplify the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to improving patient care through advanced drug delivery technologies.